Nippon Shinyaku Co., Ltd. (TYO:4516)

Japan flag Japan · Delayed Price · Currency is JPY
4,824.00
-80.00 (-1.63%)
Mar 6, 2026, 9:53 AM JST
18.35%
Market Cap 330.53B
Revenue (ttm) 166.05B
Net Income (ttm) 29.85B
Shares Out 67.40M
EPS (ttm) 442.94
PE Ratio 11.07
Forward PE 12.11
Dividend 124.00 (2.56%)
Ex-Dividend Date Mar 30, 2026
Volume 25,200
Average Volume 300,415
Open 4,834.00
Previous Close 4,904.00
Day's Range 4,781.00 - 4,858.00
52-Week Range 2,967.00 - 6,529.00
Beta -0.33
RSI 40.34
Earnings Date Feb 9, 2026

About Nippon Shinyaku

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Nippon Shinyaku to develop ATSN-10 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leb... [Read more]

Sector Healthcare
Founded 1911
Employees 2,243
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4516
Full Company Profile

Financial Performance

In fiscal year 2025, Nippon Shinyaku's revenue was 160.23 billion, an increase of 8.08% compared to the previous year's 148.26 billion. Earnings were 32.56 billion, an increase of 25.94%.

Financial Statements

News

There is no news available yet.